Evidence map›Paper›PMID 23921391›Full record

ArticleThe Journal of biological chemistry2013

The solution structure of heparan sulfate differs from that of heparin: implications for function.

Sanaullah Khan, Ka Wai Fung, Elizabeth Rodriguez, Rima Patel, Jayesh Gor, Barbara Mulloy, Stephen J Perkins

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. 3-Computational and structural biotechnology journal · 2022
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Glycosaminoglycans and Proteoglycans.Pharmaceuticals (Basel, Switzerland) · 2018
    Article
  10. Heparin Mimetics: Their Therapeutic Potential.Pharmaceuticals (Basel, Switzerland) · 2017
    Review
  11. Review
  12. Glycosaminoglycanomics: where we are.Glycoconjugate journal · 2017
    Review
  13. Article
  14. Heparan sulfate and heparin interactions with proteins.Journal of the Royal Society, Interface · 2015
    Review
  15. Journal of applied crystallography · 2015
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sanaullah KhanFrom the Department of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, United Kingdom and.
Ka Wai Fung
Elizabeth Rodriguez
Rima Patel
Jayesh Gor
Barbara Mulloy
Stephen J Perkins

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
ONCOLOGY: CHEMOTHERAPY, IMMUNOLOGY, BIOLOGYT32CA009071 · NCI · JOHNS HOPKINS UNIVERSITY · PI Mary Y Armanios, Nilofer S. Azad · 1985 to 2026
$12.8M
Biotechnology and Biological Sciences Research Council BB/E013104/1NCI NIH HHS P30 CA006973NCI NIH HHS T32 CA009071
6 · The paper itself

Abstract

The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments dp6-dp24 corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s20,w of HS dp6-dp24 showed a small rotor speed dependence, where similar s20,w values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radii of gyration RG values from 1.03 to 2.82 nm, cross-sectional radii of gyration RXS values from 0.31 to 0.65 nm, and maximum lengths L from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5,000 to 12,000 conformationally randomized HS structures gave best fit dp6-dp24 molecular structures that were longer and more bent than their equivalents in heparin. Alternative fits were obtained for HS dp18 and dp24, indicating their higher bending and flexibility. We conclude that HS displays bent conformations that are significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.

Indexed as

CrystallizationGlycosidesHeparan SulfateHeparinLigandsModels, MolecularScattering, RadiationSynchrotronsUltracentrifugationX-RaysGlycosidesHeparan SulfateHeparinLigandsAnalytical UltracentrifugationHeparan SulfateHeparinHeparin-binding ProteinMolecular ModelingX-ray Scattering

Identifiers

PMID23921391
PMCPMC3784691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.